#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1184	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2473	93.0	0	.	n	.	0	C451T	SNP	451	451	C	822	822	T	129	T,C	39,44	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1184	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2473	93.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1555	1555	C	131	C	82	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	1184	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2473	93.0	0	HET	.	.	.	C207T	.	207	207	C	578	578	C	101	C,T	50,17	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	0	.	n	.	0	T695C	SNP	695	695	T	1293	1293	C	150	C	85	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2569	2569	C	103	C	60	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2643	2643	A	94	A	63	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	3195	3195	C	144	C	95	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	0	HET	.	.	.	C1811T	.	1811	1811	C	2409	2409	C	104	C,T	51,15	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2128	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3875	103.9	0	HET	.	.	.	A1638G	.	1638	1638	A	2236	2236	A	96	A,G	50,12	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	122	folP	855	855	100.0	folP.l15.c4.ctg.1	1317	17.7	1	SNP	p	R229S	1	.	.	685	687	AGC	927	929	AGC	19;19;19	A;G;C	14;14;14	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	19	350	gyrA	2751	2602	99.85	gyrA.l15.c17.ctg.1	2913	21.9	1	SNP	p	S91F	1	.	.	271	273	TTC	133	135	TTC	18;18;18	T;T;C	11;10;11	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	19	350	gyrA	2751	2602	99.85	gyrA.l15.c17.ctg.1	2913	21.9	1	SNP	p	D95G	1	.	.	283	285	GGC	145	147	GGC	24;24;24	G;G;C	15;15;15	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	19	350	gyrA	2751	2602	99.85	gyrA.l15.c17.ctg.1	2913	21.9	1	SNP	p	G95N	0	.	.	283	285	GGC	145	147	GGC	24;24;24	G;G;C	15;15;15	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	76	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1151	13.7	1	SNP	p	G45D	0	.	.	133	135	GGC	394	396	GGC	14;15;15	G;G;C	11;11;12	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	62	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	685	16.1	0	.	n	.	0	A197.	DEL	197	197	A	302	302	A	30	A	19	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	300	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2608	21.9	1	SNP	p	D86N	0	.	.	256	258	GAC	386	388	GAC	40;40;40	G;A;C	24;20;27	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	300	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2608	21.9	1	SNP	p	S87R	1	.	.	259	261	CGT	389	391	CGT	41;40;41	C;G;T	29;25;24	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	300	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2608	21.9	1	SNP	p	R87I	0	.	.	259	261	CGT	389	391	CGT	41;40;41	C;G;T	29;25;24	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	300	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2608	21.9	1	SNP	p	R87W	0	.	.	259	261	CGT	389	391	CGT	41;40;41	C;G;T	29;25;24	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	300	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2608	21.9	1	SNP	p	S88P	0	.	.	262	264	TCC	392	394	TCC	41;41;41	T;C;C	25;27;28	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	236	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2412	18.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	3;3;3	G;G;C	2;2;2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1379	1381	GCC	39;39;39	G;C;C	23;22;23	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1382	1384	ATG	39;37;37	A,G;T;G	22,1;21;21	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1394	1396	ACC	42;42;41	A;C;C	25;25;24	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1394	1396	ACC	42;42;41	A;C;C	25;25;24	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1895	1897	ACC	19;19;17	A;C;C	14;14;15	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1949	1951	GCG	23;23;23	G;C;G	14;14;15	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1949	1951	GCG	23;23;23	G;C;G	14;14;15	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2072	2074	GGT	21;21;21	G;G;T	14;14;14	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2081	2083	AGC	23;23;23	A;G;C,G	12;14;11,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	242	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2336	19.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2099	2101	CCG	21;21;21	C;C;G	14;9;11	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	V20F	NONSYN	58	60	GTT	74	76	TTT	10;10;10	T;T;T	3;3;4	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	Q279R	NONSYN	835	837	CAG	851	853	CGG	62;62;62	C;G;G	35;37;39	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	A302T	NONSYN	904	906	GCC	920	922	ACC	66;66;66	A;C;C	39;43;42	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	V307A	NONSYN	919	921	GTG	935	937	GCG	64;64;64	G;C;G	43;41;43	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	T382A	NONSYN	1144	1146	ACG	1160	1162	GCG	27;27;27	G;C;G	21;21;20	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	N396D	NONSYN	1186	1188	AAT	1202	1204	GAT	26;24;24	G;A;T	21;14;18	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	1	SNP	p	L428P	1	L428P	NONSYN	1282	1284	CTG	1298	1300	CCG	28;28;28	C;C;G	19;19;21	ponA.Neisseria_meningitidis_MC58_v2_01817:1:1:L428P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	S556P	NONSYN	1666	1668	TCG	1682	1684	CCG	27;24;24	C;C;G	21;20;20	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	1901	98.42	ponA.l15.c4.ctg.1	1917	32.1	0	.	p	.	0	V591G	NONSYN	1771	1773	GTT	1787	1789	GGT	9;9;9	G;G;T	7;3;6	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	V694A	NONSYN	2080	2082	GTC	344	346	GCC	33;33;33	G;C;C	19;19;19	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	T747M	NONSYN	2239	2241	ACG	503	505	ATG	18;18;18	A;T;G	12;13;13	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	G766E	NONSYN	2296	2298	GGG	560	562	GAA	26;26;26	G;A;A	19;19;18	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	G767A	NONSYN	2299	2301	GGC	563	565	GCG	26;26;26	G;C;G	18;17;18	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	A769V	NONSYN	2305	2307	GCA	569	571	GTA	26;26;26	G;T;A	19;17;19	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	G771N	NONSYN	2311	2313	GGC	575	577	AAC	24;24;24	A;A;C	16;16;18	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	G772E	NONSYN	2314	2316	GGA	578	580	GAA	24;24;24	G;A;A	17;18;18	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	R773Q	NONSYN	2317	2319	CGG	581	583	CAG	24;24;24	C;A;G	17;18;16	.	.
ponA.Neisseria_meningitidis_MC58_v2_01817	ponA.Neisseria_meningitidis_MC58_v2_01817	1	1	517	498	ponA	2418	682	94.58	ponA.l15.c4.ctg.2	1139	22.4	0	.	p	.	0	A775fs	FSHIFT	2323	2323	G	587	587	G	24	G	18	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	112	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1655	12.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	7	C	4	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	176	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1395	23.5	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	322	324	CAG	15;15;15	C;A;G	11;12;12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	176	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1395	23.5	1	SNP	p	G120K	1	.	.	358	360	AAG	562	564	AAG	25;24;25	A;A;G,A	16;16;18,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	176	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1395	23.5	1	SNP	p	A121N	1	.	.	361	363	AAC	565	567	AAC	25;25;25	A;A;C	18;16;17	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	176	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1395	23.5	1	SNP	p	N121D	0	.	.	361	363	AAC	565	567	AAC	25;25;25	A;A;C	18;16;17	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	486	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4740	20.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	48	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	790	10.3	1	SNP	p	V57M	1	.	.	169	171	ATG	356	358	ATG	14;14;14	A;T;G	9;9;8	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
